Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00090220
Status:
COMPLETED
Last Update Posted:
2017-04-21
First Post:
2004-08-25
Brief Title:
A Study to Evaluate the Safety Immune Response and Efficacy of Gardasil V501 qHPV in Mid-Adult Women V501-019
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Human Papillomavirus Recombinant Vaccine Quadrivalent Types 6 11 16 18 |
| Healthy Adult Female Participants |
| Prevention |
| Papillomavirus Infection |
Keywords: